NCT03098732 - Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2020

Conditions

Stroke, AcuteStroke, IschemicInfarction, Middle Cerebral ArteryStrokes ThromboticNeurologic DisorderCerebrovascular DisordersIntracranial Embolism and Thrombosis

Interventions

DEVICE

Magnetically Enhanced Diffusion (MED)

Treatment of Acute Ischemic Stroke with IV tPA and the adjunctive Magnetically Enhanced Diffusion (MED) System Procedure.

DEVICE

MED Workstation Magnet Sham Control

Treatment of Acute Ischemic Stroke with IV tPA and Sham use of the MED Workstation only, without the injection of MED MicroBeads.

Trial Locations (2)

G51 4TF

Queen Elizabeth University Hospital, Glasgow

CH2 1UL

Countess of Chester Hospital NHS Foundation Trust, Chester